cached image

Mark Stuart Forman, MD, Duke University 1995, PhD, Rockefeller University 1994

Experimental Medicine Merck Pharmaceuticals, Lincoln, NJ, United States 
Molecular pathogeneis of neurodegenerative disease
"Mark Forman"

PO BOX 1000
NORTH WALES, PA 194541099
United States

Mean distance: 14.88 (cluster 24)
Cross-listing: Neuropathology Tree - Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rabinovici GD, Carrillo MC, Forman M, et al. (2017) Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development. Alzheimer's & Dementia (New York, N. Y.). 3: 83-91
Scott JD, Li SW, Brunskill AP, et al. (2016) Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry. 59: 10435-10450
Hu WT, McMillan C, Libon D, et al. (2010) Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology. 75: 595-602
Ritson GP, Custer SK, Freibaum BD, et al. (2010) TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 7729-39
Gitcho MA, Strider J, Carter D, et al. (2009) VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. The Journal of Biological Chemistry. 284: 12384-98
Neumann M, Kwong LK, Lee EB, et al. (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathologica. 117: 137-49
Weihl CC, Temiz P, Miller SE, et al. (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 1186-9
Uryu K, Nakashima-Yasuda H, Forman MS, et al. (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. Journal of Neuropathology and Experimental Neurology. 67: 555-64
Bian H, Van Swieten JC, Leight S, et al. (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology. 70: 1827-35
Grossman M, Xie SX, Libon DJ, et al. (2008) Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology. 70: 2036-45
See more...